0001596783-21-000045.txt : 20210322 0001596783-21-000045.hdr.sgml : 20210322 20210322141956 ACCESSION NUMBER: 0001596783-21-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210318 FILED AS OF DATE: 20210322 DATE AS OF CHANGE: 20210322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiminski John R CENTRAL INDEX KEY: 0001482197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 21760957 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_161643718240512.xml FORM 4 X0306 4 2021-03-18 0 0001596783 Catalent, Inc. CTLT 0001482197 Chiminski John R C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 1 1 0 0 Chair & CEO Common Stock 2021-03-18 4 M 0 42220 36.02 A 205838 D Common Stock 2021-03-18 4 S 0 42220 105.16 D 163618 D Common Stock 2021-03-19 4 M 0 35588 36.02 A 199206 D Common Stock 2021-03-19 4 M 0 45792 34.91 A 244998 D Common Stock 2021-03-19 4 M 0 69270 43.88 A 314268 D Common Stock 2021-03-19 4 M 0 32374 54.94 A 346642 D Common Stock 2021-03-19 4 S 0 70583 105.64 D 276059 D Common Stock 2021-03-19 4 S 0 111641 106.24 D 164418 D Common Stock 2021-03-19 4 S 0 800 107.07 D 163618 D Options to purchase Common Stock 36.02 2021-03-18 4 M 0 42220 0 D 2027-07-24 Common Stock 42220.0 61527 D Options to purchase Common Stock 36.02 2021-03-19 4 M 0 35588 0 D 2027-07-24 Common Stock 35588.0 25939 D Options to purchase Common Stock 34.91 2021-03-19 4 M 0 45792 0 D 2027-08-23 Common Stock 45792.0 15264 D Options to purchase Common Stock 43.88 2021-03-19 4 M 0 69270 0 D 2028-07-23 Common Stock 69270.0 69273 D Options to purchase Common Stock 54.94 2021-03-19 4 M 0 32374 0 D 2029-07-22 Common Stock 32374.0 97123 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. Includes restricted stock units. Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The options vest and become exercisable in four equal annual installments beginning on July 24, 2018. The options vest and become exercisable in four equal annual installments beginning on August 23, 2018. The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. /s/ Jose Ibietatorremendia, attorney-in-fact 2021-03-22